Skip to main content

Antigout Drugs

  • Living reference work entry
  • First Online:
  • 165 Accesses

Synonyms

Drugs for the treatment/management of gout and/or hyperuricemia

Definition

Pathophysiology and Clinical Manifestations of Gout

Uric acid is the end product of purine catabolism in man. Purines originate from food and the degradation of nucleic acids and nucleotides. Xanthine oxidase (XOD) is the key enzyme in purine degradation. XOD converts hypoxanthine to xanthine and xanthine to uric acid, respectively (Fig. 1). Uric acid is filtered in the glomerulus of the kidney, is almost completely absorbed in the proximal tubules, and secreted more distally (Fig. 2). At physiological pH (<7.4), uric acid exists predominantly in its ionic form (urate). At lower pH, the fraction of uric acid molecules (protonized form) increases. This is important because uric acid possesses a lower solubility than urate. Thus, a decrease in pH, as it occurs in inflammed tissue and in the tubules, facilitates the formation of uric acid crystals, which are the initial cause of gout. Of importance for...

This is a preview of subscription content, log in via an institution.

References

  • Emmerson BT (1996) The management of gout. New Engl J Med 334:445–451

    Article  CAS  Google Scholar 

  • Frampton JE (2015) Febuxostat: a review of its use in the treatment of hyperuricemia in patients with gout. Drugs 75:427–438

    Article  CAS  Google Scholar 

  • Khanna PP, Gladue HS, Singh MK, FitzGerald JD, Bae S, Prakash S, Kaldas M, Gogia M, Berrcal V, Townsend W, Terkeltaub R, Khanna D (2014) Treatment of acute gout: a systematic review. Semin Arthritis Rheum 44:31–38

    Article  CAS  Google Scholar 

  • Lange U, Schumann C, Schmidt KL (2001) Current aspects of colchicine therapy. Classical indications and new therapeutic uses. Eur J Med Res 6:150–160

    CAS  PubMed  Google Scholar 

  • Schlesinger N, Schuhmacher HRHR Jr (2001) Gout: can management be improved? Curr Opin Rheumatol 13:240–244

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roland Seifert .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer-Verlag Berlin Heidelberg New York

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Seifert, R. (2020). Antigout Drugs. In: Offermanns, S., Rosenthal, W. (eds) Encyclopedia of Molecular Pharmacology. Springer, Cham. https://doi.org/10.1007/978-3-030-21573-6_10-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21573-6_10-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21573-6

  • Online ISBN: 978-3-030-21573-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics